Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR -2.24%67 Net Margin % is 20.59% as of Mar. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 67/100 and a GF Value™ of kr2.35 (Modestly Overvalued). Among 817 Medical Devices & Instruments companies, Medclair AB ranks better than 67.81% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Medclair AB's Net Income for the
three
months ended in Mar. 2026 was kr3.76 Mil. Medclair AB's Revenue for the
three
months ended in Mar. 2026 was kr18.24 Mil. Therefore, Medclair AB's net margin for the quarter that ended in Mar. 2026 was 20.59%.
The historical rank and industry rank for Medclair AB's Net Margin % or its related term are showing as below:
NGM:MCLR'
s Net Margin % Range Over the Past 10 Years
Min: -134 Med: -26.15 Max: 8.93
Current: 8.15
NGM:MCLR's Net Margin % is ranked better than 67.81% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs NGM:MCLR: 8.15
Medclair AB (NGM:MCLR) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Medclair AB Net Margin % Related Terms
Medclair AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Medclair AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:MCLR vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Medclair AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Medclair AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medclair AB (NGM:MCLR) has a Net Margin % of 20.59% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Medclair AB and its competitors. According to the industry distribution chart, Medclair AB ranks #263 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 32.2%.
Is Medclair AB's Net Margin % too high?
Medclair AB's current Net Margin % is 20.59%. The Medical Devices & Instruments industry median Net Margin % is 2.05. Medclair AB's value of 20.59% is 904.4% above this industry median. Based on the distribution chart, Medclair AB ranks #263 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medclair AB has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #263 out of 817 companies for Net Margin %. This puts Medclair AB in the upper half of its industry. The industry median Net Margin % is 2.05. Medclair AB's value of 20.59% is 904.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medclair AB's current Net Margin % of 20.59% is 904.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medclair AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medclair AB's current Net Margin % is 20.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Modestly Overvalued. The stock's GF Value™ is kr2.35, compared to a current price of kr3.05 — trading 29.8% above its estimated fair value. The current Net Margin % is 20.59% and 904.4% above the Medical Devices & Instruments industry median of 2.05. Medclair AB's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Net Margin % is 20.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr3.05 is trading 29.8% above its estimated GF Value™ of kr2.35.
GuruFocus considers Medclair AB to be Modestly Overvalued.
Key valuation signals for NGM:MCLR:
Net Margin %: 20.59%
GF Value™: kr2.35 vs. price of kr3.05 (29.8% above fair value)
Industry Position: 904.4% above the Medical Devices & Instruments median (#263 of 817)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
67GF Score
Get the complete analysis for NGM:MCLR
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
